Apr 27, 2015 8:31 am EDT iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics
Dec 10, 2014 8:31 am EST iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting